2003
DOI: 10.1046/j.1523-1755.2003.00809.x
|View full text |Cite
|
Sign up to set email alerts
|

Dose-dependent effects of strontium on bone of chronic renal failure rats

Abstract: Our findings indicate that the role of Sr in the development of bone lesions in renal failure is complex and that, depending on the dose, the element may act via multiple pathways.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
44
0
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(51 citation statements)
references
References 27 publications
(13 reference statements)
6
44
0
1
Order By: Relevance
“…Objective 10x. © C I C E d i z i o n i I n t e r n a z i o n a l i chemical crystal properties (37,38). Our finding agree with previous data obtained by our research group, according to which strontium can distinctly induce proliferation or mineralization activity on human adipose tissue-derived mesenchymal stem cells, according to the used high or low concentrations (10).…”
Section: Discussionsupporting
confidence: 90%
“…Objective 10x. © C I C E d i z i o n i I n t e r n a z i o n a l i chemical crystal properties (37,38). Our finding agree with previous data obtained by our research group, according to which strontium can distinctly induce proliferation or mineralization activity on human adipose tissue-derived mesenchymal stem cells, according to the used high or low concentrations (10).…”
Section: Discussionsupporting
confidence: 90%
“…In many instances, the pathogenesis of the precise type of ROD in a given patient seems to be obvious, for instance secondary hyperparathyroidism for osteitis fibrosa, vitamin D deficiency or aluminum overload for osteomalacia, hypoparathyroidism for adynamic bone disease, and advanced age and female gender for osteoporosis. However, other factors may also play a role, including abnormal levels or functions of hormones involved in mineral metabolism (other than parathyroid hormone [PTH] and calcitriol), in gonadal function, or in energy metabolism (in particular diabetes) (7); abnormal growth factors or cytokine levels and dysfunction of their receptors (8,9); acidosis (10); oxidative stress and advanced glycation end products (11); uremic toxins (12,13); metal overload (14,15); insufficient mechanical loading (8); and inappropriate diets and malnutrition (16,17). A better understanding, at the patient level and the molecular level, of the underlying pathogenesis and the risk factors involved in ROD including osteoporosis might help to prevent this important health problem in the patient population with CKD (6).…”
mentioning
confidence: 99%
“…In the long run, this may decrease skeletal calcium content. Besides being incorporated into hydroxyapatite, Sr can be adsorbed at the crystal surface and was shown to inhibit subsequent crystal growth [11,12,26,27] . Beyond these effects on apatite formation, Sr was shown to interfere with osteoblast differentiation in vitro already at low extracellular concentrations [28] .…”
Section: Discussionmentioning
confidence: 99%
“…In experimental uremia, high dosages of Sr induce mineralization defects and osteomalacia [11,12] . Likewise, osteomalacia in CKD patients on hemodialysis has been strongly associated with the Sr concentration in dialysis fluids and probably additional effects related to Sr-contaminated phosphate binders [7,13] .…”
Section: Moderate Strontium Loading Induces Rickets In Rats With Mildmentioning
confidence: 99%